-
Something wrong with this record ?
Postoperative high-dose-rate brachytherapy alone in stage T1-3N0M0 oral cancer with negative prognostic factors: A retrospective study
L. Tuček, I. Sirák, D. Pohanková, L. Kašaová, J. Grepl, P. Paluska, M. Hodek, M. Vošmik, BA. Mustafa, E. Čermánková, J. Petera
Language English Country United States
Document type Journal Article
- MeSH
- Brachytherapy * methods MeSH
- Radiotherapy Dosage * MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Survival Rate MeSH
- Mouth Neoplasms * radiotherapy pathology surgery MeSH
- Prognosis MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Neoplasm Staging * MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
PURPOSE: To evaluate treatment outcomes and toxicity in patients with stage T1-3N0M0 oral cancer treated with surgery followed by high-dose-rate brachytherapy (HDR-BT). METHODS AND MATERIALS: Retrospective study of 50 patients with stage T1-T3N0 tongue and floor-of-mouth cancer who underwent tumour excision (+ elective neck dissection) followed by postoperative HDR-BT due to the presence of negative prognostic factors (close or positive resection margins, lymphovascular and/or perineural invasion, deep invasion). The plastic tube technique (dose: 18 x 3 Gy b.i.d.) was used. Survival outcomes, toxicity, and prognostic factors were evaluated. RESULTS: At a median follow-up of 81 months (range, 4-121), actuarial 5-year local control (LC), nodal control (NC) and progression-free survival (PFS) rates were 79%, 69%, and 64%. After salvage treatment (surgery + external beam radiotherapy), LC, NC, and PFS increased to 87%, 77%, and 72.3%, respectively. Five-year overall survival and cancer-specific survival (CSS) rates were 73% and 77%. Treatmentrelated toxicity included two cases of mandibular osteoradionecrosis and five cases of small soft tissue necrosis. T stage was significantly correlated with nodal control (p=0.02) and CSS (p=0.04). Tumour grade correlated with DFS (p=0.01). CONCLUSION: Postoperative HDR-BT 18 x 3 Gy b.i.d. seems to be an effective method in patients with T1-3N0M0 oral cancer with negative prognostic factors after tumour resection.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009721
- 003
- CZ-PrNML
- 005
- 20250429135007.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.brachy.2024.03.001 $2 doi
- 035 __
- $a (PubMed)39721873
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tuček, Luboš $u Department of Stomatosurgery, University Hospital and Medical Faculty Hradec Kralove, Hradec Kralove, Czech Republic
- 245 10
- $a Postoperative high-dose-rate brachytherapy alone in stage T1-3N0M0 oral cancer with negative prognostic factors: A retrospective study / $c L. Tuček, I. Sirák, D. Pohanková, L. Kašaová, J. Grepl, P. Paluska, M. Hodek, M. Vošmik, BA. Mustafa, E. Čermánková, J. Petera
- 520 9_
- $a PURPOSE: To evaluate treatment outcomes and toxicity in patients with stage T1-3N0M0 oral cancer treated with surgery followed by high-dose-rate brachytherapy (HDR-BT). METHODS AND MATERIALS: Retrospective study of 50 patients with stage T1-T3N0 tongue and floor-of-mouth cancer who underwent tumour excision (+ elective neck dissection) followed by postoperative HDR-BT due to the presence of negative prognostic factors (close or positive resection margins, lymphovascular and/or perineural invasion, deep invasion). The plastic tube technique (dose: 18 x 3 Gy b.i.d.) was used. Survival outcomes, toxicity, and prognostic factors were evaluated. RESULTS: At a median follow-up of 81 months (range, 4-121), actuarial 5-year local control (LC), nodal control (NC) and progression-free survival (PFS) rates were 79%, 69%, and 64%. After salvage treatment (surgery + external beam radiotherapy), LC, NC, and PFS increased to 87%, 77%, and 72.3%, respectively. Five-year overall survival and cancer-specific survival (CSS) rates were 73% and 77%. Treatmentrelated toxicity included two cases of mandibular osteoradionecrosis and five cases of small soft tissue necrosis. T stage was significantly correlated with nodal control (p=0.02) and CSS (p=0.04). Tumour grade correlated with DFS (p=0.01). CONCLUSION: Postoperative HDR-BT 18 x 3 Gy b.i.d. seems to be an effective method in patients with T1-3N0M0 oral cancer with negative prognostic factors after tumour resection.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a brachyterapie $x metody $7 D001918
- 650 12
- $a nádory úst $x radioterapie $x patologie $x chirurgie $7 D009062
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a celková dávka radioterapie $7 D011879
- 650 12
- $a staging nádorů $7 D009367
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a míra přežití $7 D015996
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sirák, Igor $u Department of Oncology and Radiotherapy, University Hospital and Medical Faculty Hradec Kralove Hradec Kralove, Czech Republic. Electronic address: igor.sirak@fnhk.cz
- 700 1_
- $a Pohanková, Denisa $u Department of Oncology and Radiotherapy, University Hospital and Medical Faculty Hradec Kralove Hradec Kralove, Czech Republic
- 700 1_
- $a Kašaová, Linda $u Department of Oncology and Radiotherapy, University Hospital and Medical Faculty Hradec Kralove Hradec Kralove, Czech Republic
- 700 1_
- $a Grepl, Jakub $u Department of Oncology and Radiotherapy, University Hospital and Medical Faculty Hradec Kralove Hradec Kralove, Czech Republic
- 700 1_
- $a Paluska, Petr $u Department of Oncology and Radiotherapy, University Hospital and Medical Faculty Hradec Kralove Hradec Kralove, Czech Republic
- 700 1_
- $a Hodek, Miroslav $u Department of Oncology and Radiotherapy, University Hospital and Medical Faculty Hradec Kralove Hradec Kralove, Czech Republic
- 700 1_
- $a Vošmik, Milan $u Department of Oncology and Radiotherapy, University Hospital and Medical Faculty Hradec Kralove Hradec Kralove, Czech Republic
- 700 1_
- $a Mustafa, Banni Aml $u Department of Oncology and Radiotherapy, University Hospital and Medical Faculty Hradec Kralove Hradec Kralove, Czech Republic
- 700 1_
- $a Čermánková, Eva $u Computer Technique Center, Medical Faculty Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Petera, Jiří $u Department of Oncology and Radiotherapy, University Hospital and Medical Faculty Hradec Kralove Hradec Kralove, Czech Republic
- 773 0_
- $w MED00008587 $t Brachytherapy $x 1873-1449 $g Roč. 24, č. 2 (2025), s. 273-280
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39721873 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135002 $b ABA008
- 999 __
- $a ok $b bmc $g 2311223 $s 1246802
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 24 $c 2 $d 273-280 $e 20241224 $i 1873-1449 $m Brachytherapy $n Brachytherapy $x MED00008587
- LZP __
- $a Pubmed-20250415
